The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Rogers, director of the Penn State surgical weight loss program ... found more than half the people prescribed weight loss ...

Customs officers intercepted a passenger at Dublin Airport carrying €12,000 worth of potentially dangerous "skinny pen" ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

with the potential for a 15% weight loss after 68 weeks in adults with a BMI of 30 or greater [1]. Like Ozempic, Wegovy is also prescription only and taken once a week. Saxenda, like Ozempic and ...

Novo Nordisk’s Saxenda ... t lose at least 5% of their body eight within 12 months. “Our independent committee was presented with clinical evidence which showed that people lose more weight ...

the telehealth operators either featured the Saxenda pen with its label covered, or used a blue pen that resembles the product. Some operators called it a “skinny pen” or “weight-loss pen ...

If you’re taking — or thinking about taking — a GLP-1 medication like Ozempic®, Wegovy®, or Saxenda®, you don ... and healthy fats can support your weight loss efforts and help you ...